AAX Biotech Featured in Ventures Accelerated Interview at NLSDays 2025

We are pleased to share highlights from our recent interview with Ventures Accelerated during the Nordic Life Science Days (NLSDays) 2025 conference in Gothenburg, where AAX Biotech pitched as a finalist in the Nordic Star Pitch Competition. 

Our CBO, Maria L. Knudsen, sat down to discuss how our unique platforms, Seqitope® and Opti-mAb®, are "developing unique solutions to known problems in the next generation of antibody therapeutics, thereby accelerating drug development and reducing potential failures in the process. Maria noted that pitching and connecting with fellow innovators at NLSDays was a great platform for making personal connections and for raising our profile internationally. 

Building on this momentum, we are now focused on expanding our collaborations, further innovating our platforms, and gearing up for the next funding round, signaling really exciting times coming up for AAX Biotech. 

Watch the full interview below: